LISA BEAVERS: Open Payments
NPI 1700373289 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 31 payments from 11 companies in 2025. Trend: 2023 $576 · 2024 $728 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $261 |
| Dexcom, Inc. | 2 | $117 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Tactile Systems Technology Inc | 2 | $47 |
| PFIZER INC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
| Lilly USA, LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Ozempic, DEXCOM G7 GSS (161), AIRSUPRA, Wegovy, Flexitouch Plus, BREZTRI, The Cologuard Plus Collection Kit, PREVNAR 20.
Industry payments across DE — which companies pay providers there.
